Envoy Medical (NASDAQ:COCH) Price Target Raised to $9.00 at Ascendiant Capital Markets

Envoy Medical (NASDAQ:COCH) had its price target hoisted by Ascendiant Capital Markets from $8.75 to $9.00 in a research note issued to investors on Friday morning,Benzinga reports. Ascendiant Capital Markets currently has a buy rating on the stock.

Separately, Brookline Capital Management started coverage on shares of Envoy Medical in a report on Monday, October 14th. They set a “buy” rating and a $9.00 price target on the stock.

Envoy Medical Price Performance

NASDAQ COCH opened at $2.20 on Friday. The business has a fifty day simple moving average of $2.44 and a 200 day simple moving average of $2.57. Envoy Medical has a 12 month low of $1.08 and a 12 month high of $11.46.

Envoy Medical Company Profile

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.